Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,115 | -20,812 | -20,838 | -19,592 | -17,213 |
| Depreciation Amortization | 2,769 | 2,020 | 2,145 | 2,279 | 2,433 |
| Accounts receivable | -1,162 | 67 | 258 | 2,406 | -1,785 |
| Accounts payable and accrued liabilities | 240 | -96 | -448 | -479 | -2,050 |
| Other Working Capital | -965 | -161 | -196 | 1,936 | -3,836 |
| Other Operating Activity | 567 | 3,821 | 3,150 | 1,757 | 10,044 |
| Operating Cash Flow | $-17,666 | $-15,161 | $-15,929 | $-11,693 | $-12,407 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 38,039 | 17,727 | 15,835 | 4,831 | 18,439 |
| PPE Investments | -900 | -374 | -590 | -803 | -2,005 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 953 |
| Investing Cash Flow | $37,139 | $17,353 | $15,245 | $4,028 | $17,387 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,000 | 9 | 683 | 186 | 296 |
| Other Financing Activity | -694 | 288 | 131 | 469 | -251 |
| Financing Cash Flow | $9,306 | $297 | $814 | $655 | $45 |
| Exchange Rate Effect | 159 | -114 | 69 | 25 | -17 |
| Beginning Cash Position | 5,810 | 3,435 | 3,236 | 10,221 | 5,213 |
| End Cash Position | 34,748 | 5,810 | 3,435 | 3,236 | 10,221 |
| Net Cash Flow | $28,938 | $2,375 | $199 | $-6,985 | $5,008 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,666 | -15,161 | -15,929 | -11,693 | -12,407 |
| Capital Expenditure | -900 | -374 | -590 | -808 | -2,005 |
| Free Cash Flow | -18,566 | -15,535 | -16,519 | -12,501 | -14,412 |